Scienture Holdings Inc (SCNX)

09:39 AM

What analysts say about Scienture Holdings Inc. stockTremendous portfolio expansion - jammulinksnews.com

09:39 AM

06:58 AM

What drives Scienture Holdings Inc. stock priceExplosive earnings growth - Autocar Professional

06:58 AM

Jul 22, 2025

Scienture Holdings Inc. Stock Analysis and ForecastRapid-fire capital growth - Autocar Professional

Jul 22, 2025

Jul 22, 2025

Is Scienture Holdings Inc. a good long term investmentConsistent high-yield stocks - Autocar Professional

Jul 22, 2025

Jul 19, 2025

Scienture Holdings regains compliance with Nasdaq listing requirements - MSN

Jul 19, 2025

Jul 19, 2025

Why did SCNX's Q2 2023 earnings exceed forecasts significantly? - AInvest

Jul 19, 2025

Jul 16, 2025

Scienture regains Nasdaq compliance as stock price exceeds $1 By Investing.com - Investing.com South Africa

Jul 16, 2025

Jul 16, 2025

Scienture regains Nasdaq compliance as stock price exceeds $1 - Investing.com

Jul 16, 2025

Jul 16, 2025

Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - The Manila Times

Jul 16, 2025

Jul 16, 2025

Scienture Meets $1 Nasdaq Requirement as FDA-Approved Drug Launch Approaches - Stock Titan

Jul 16, 2025

Jul 15, 2025

Why Scienture Holdings Inc. stock attracts strong analyst attentionHigh Return Intraday Picks - beatles.ru

Jul 15, 2025

Jul 15, 2025

How Scienture Holdings Inc. stock performs during market volatilityCapital Doubling Tips - Newser

Jul 15, 2025

Jul 15, 2025

What makes Scienture Holdings Inc. stock price move sharplyHigh Return Intraday Picks - Newser

Jul 15, 2025

Jul 04, 2025

Scienture Holdings Secures Indemnification for Leadership - The Globe and Mail

Jul 04, 2025

Jul 03, 2025

Is Scienture Holdings (NASDAQ:SCNX) Using Debt Sensibly? - simplywall.st

Jul 03, 2025

Jun 17, 2025

Scienture Holdings terminates equity line of credit ahead of product launch - Investing.com

Jun 17, 2025

Jun 17, 2025

Scienture Holdings Announces Cancelation of ELOC | SCNX Stock Ne - GuruFocus

Jun 17, 2025

Jun 17, 2025

Scienture Holdings Announces Cancelation of ELOC - The Manila Times

Jun 17, 2025

Jun 17, 2025

Scienture Holdings Announces Cancelation of ELOC | SCNX Stock News - GuruFocus

Jun 17, 2025

Jun 17, 2025

Scienture Holdings, Inc. Terminates Equity Line of Credit to Focus on Launching FDA-Approved Arbli - Nasdaq

Jun 17, 2025

Jun 17, 2025

Scienture Terminates $310M Credit Line to Focus on Revolutionary Liquid Hypertension Drug Launch - Stock Titan

Jun 17, 2025

May 23, 2025

Scienture appoints Hariharan, Mani as co-CEOs - MSN

May 23, 2025

May 22, 2025

SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz

May 22, 2025

May 22, 2025

Scienture Appoints Co-CEOs as Suren Ajjarapu Steps Down - marketscreener.com

May 22, 2025

May 22, 2025

SCIENTURE Announces Executive Leadership Transition | SCNX Stock News - GuruFocus

May 22, 2025

May 22, 2025

SCIENTURE Announces Executive Leadership Transition - The Manila Times

May 22, 2025

May 22, 2025

Scienture Holdings, Inc. Announces Leadership Transition as Suren Ajjarapu Steps Down as CEO and Chairman - Nasdaq

May 22, 2025

May 22, 2025

Scienture Names Two Pharma Veterans as Co-CEOs in Strategic Leadership Overhaul - Stock Titan

May 22, 2025

May 19, 2025

SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, - GuruFocus

May 19, 2025

May 19, 2025

Scienture Holdings, Inc. Announces FDA Patent Listing for Arbli™, First FDA-Approved Liquid Losartan Formulation - Nasdaq

May 19, 2025

May 19, 2025

SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. - The Manila Times

May 19, 2025

May 19, 2025

FDA Orange Book Milestone: First-Ever Liquid Losartan Secures Patent Protection Until 2041 - Stock Titan

May 19, 2025

May 19, 2025

Long-Term Bull Put Spread Provides Opportunities for ARM Bulls - The Globe and Mail

May 19, 2025